Mississauga, Canada

Sammy A Agudoawu

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 3 CIPO patents and 7 EPO patents. Top assignee: Eirgen Pharma Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sammy A Agudoawu. Retrieved from https://idiyas.com/inventor/sammy-a-agudoawu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Journey of Inventor Sammy A. Agudoawu

Introduction

Sammy A. Agudoawu, based in Mississauga, Canada, is an accomplished professional with notable experience in the biotechnology and therapeutics sectors. While he currently does not hold any patents, his contributions to the field through his work with various companies demonstrate his commitment to innovation and development.

Latest Patents

As of now, Sammy A. Agudoawu has not filed any patents. However, his role in advancing research and development will likely lead to innovative contributions in the future.

Career Highlights

Sammy has worked with prominent organizations in the biotechnology field, most notably Cytochroma Inc. and Proventiv Therapeutics, LLC. His experience in these companies has provided him with a wealth of knowledge and expertise in therapeutic innovations.

Collaborations

Throughout his career, Sammy has collaborated with talented individuals, including his coworker Samir P. Tabash. This partnership likely enriched both of their capabilities in driving forward-thinking solutions in their respective projects.

Conclusion

Though currently without patents, Sammy A. Agudoawu's journey in the biotechnology landscape reveals a promising trajectory. His professional experience and collaborations point towards a significant potential for future innovations that could enhance the field of therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…